Cargando…
DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma
BACKGROUND: Lung squamous cell carcinoma (LUSC) is prone to metastasis and likely to develop resistance to chemotherapeutic drugs. DNA repair has been reported to be involved in the progression and chemoresistance of LUSC. However, the relationship between LUSC patient prognosis and DNA damage repai...
Autores principales: | Wang, Xinshu, Huang, Zhiyuan, Li, Lei, Wang, Guangxue, Dong, Lin, Li, Qinchuan, Yuan, Jian, Li, Yunhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361681/ https://www.ncbi.nlm.nih.gov/pubmed/35941578 http://dx.doi.org/10.1186/s12885-022-09954-x |
Ejemplares similares
-
The Role of Alternative Splicing Factors, DDB2-Related Ageing and DNA Damage Repair in the Progression and Prognosis of Stomach Adenocarcinoma Patients
por: Wang, Xinshu, et al.
Publicado: (2022) -
Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis
por: Jia, Bin, et al.
Publicado: (2022) -
Construction of a DNA damage repair gene signature for predicting prognosis and immune response in breast cancer
por: Chang, Yiming, et al.
Publicado: (2023) -
Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma
por: Zhu, Lei, et al.
Publicado: (2021) -
Identify a DNA Damage Repair Gene Signature for Predicting Prognosis and Immunotherapy Response in Cervical Squamous Cell Carcinoma
por: Zhou, Hong, et al.
Publicado: (2022)